Cargando…
Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
Raloxifene hydrochloride (RLX) shows poor bioavailability (<2%), high inter-patient variability and extensive gut metabolism (>90%). The objective of this study was to develop nanostructured lipid carriers (NLCs) for RLX to enhance its bioavailability. The NLC formulations were produced with g...
Autores principales: | Murthy, Aditya, Rao Ravi, Punna, Kathuria, Himanshu, Malekar, Shrinivas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353254/ https://www.ncbi.nlm.nih.gov/pubmed/32486508 http://dx.doi.org/10.3390/nano10061085 |
Ejemplares similares
-
Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
por: Patel, B. Divyakant, et al.
Publicado: (2012) -
Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability
por: Kushwaha, Anand Kumar, et al.
Publicado: (2013) -
Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers
por: Zhou, Jun, et al.
Publicado: (2015) -
Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
por: Peczek, Samila Horst, et al.
Publicado: (2023) -
Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity
por: Zaky, Mohamed F., et al.
Publicado: (2022)